State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of approximately 5% of Expedia Group Inc's common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 965,610 shares of common stock in Everspin Technologies Inc as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a beneficial ownership position of 212,943,706 shares, representing 5.1% of the common stock of ExxonMobil Holdings Corp, as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 3,870,076 shares of EPR Properties common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in DexCom Inc common stock as of the event date of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 3,874,849 shares of Delek US Holdings Inc common stock as of September 30, 2026.
Legend Biotech Corporation filed a Form 6-K on November 10, 2026, furnishing unaudited interim condensed consolidated financial statements and management's discussion and analysis for the three and nine months ended September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of approximately 5.2% of Dollar Tree Inc's common stock as of September 30, 2026.
Palladyne AI Corp. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 10, 2026, covering the fiscal quarter ended September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 6,158,254 shares of DuPont de Nemours Inc common stock as of September 30, 2026.